Interferon beta-1a for COVID-19: critical importance of the administration route

dc.contributor.authorJuho Jalkanen
dc.contributor.authorMaija Hollmén
dc.contributor.authorSirpa Jalkanen
dc.contributor.organizationfi=MediCity|en=MediCity|
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code1.2.246.10.2458963.20.83772236069
dc.converis.publication-id49369072
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/49369072
dc.date.accessioned2022-10-28T13:37:04Z
dc.date.available2022-10-28T13:37:04Z
dc.identifier.eissn1466-609X
dc.identifier.jour-issn1364-8535
dc.identifier.olddbid183133
dc.identifier.oldhandle10024/166227
dc.identifier.urihttps://www.utupub.fi/handle/11111/40481
dc.identifier.urnURN:NBN:fi-fe2021042822556
dc.language.isoen
dc.okm.affiliatedauthorHollmen, Maija
dc.okm.affiliatedauthorJalkanen, Sirpa
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeB1 Scientific Journal
dc.publisherBMC
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumberARTN 335
dc.relation.doi10.1186/s13054-020-03048-5
dc.relation.ispartofjournalCritical Care
dc.relation.issue1
dc.relation.volume24
dc.source.identifierhttps://www.utupub.fi/handle/10024/166227
dc.titleInterferon beta-1a for COVID-19: critical importance of the administration route
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s13054-020-03048-5.pdf
Size:
216.13 KB
Format:
Adobe Portable Document Format
Description:
Publisher's version